<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="miyoshi" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">miyoshi</book-part-id>
      <title-group>
        <title>Dysferlinopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aoki</surname>
            <given-names>Masashi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <email>aokim@med.tohoku.ac.jp</email>
          <aff>Department of Neurology<break/>Tohoku University School of Medicine<break/>Sendai, Japan</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2004-02-05" date-type="created">
          <day>5</day>
          <month>2</month>
          <year>2004</year>
        </date>
        <date iso-8601-date="2015-03-05" date-type="updated">
          <day>5</day>
          <month>3</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="duarte-gal" document-type="chapter">Duarte Variant Galactosemia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="dkc" document-type="chapter">Dyskeratosis Congenita</related-object>
      <abstract id="miyoshi.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Dysferlinopathy includes a spectrum of muscle disease characterized by two main phenotypes: Miyoshi myopathy with primarily distal weakness and limb-girdle muscular dystrophy type 2B (LGMD2B) with primarily proximal weakness. Miyoshi myopathy (median age of onset 19 years) is characterized by muscle weakness and atrophy, most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. LGMD2B is characterized by early weakness and atrophy of the pelvic and shoulder girdle muscles in adolescence or young adulthood, with slow progression. Other phenotypes are scapuloperoneal syndrome, distal myopathy with anterior tibial onset, elevated serum CK concentration only, and congenital muscular dystrophy.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis depends on a combination of muscle biopsy and molecular genetic testing. Muscle biopsy western immunoblotting almost always indicates a primary dysferlinopathy. <italic toggle="yes">DYSF</italic>, which encodes the protein dysferlin, is the only gene in which pathogenic variants are known to cause dysferlinopathy</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Individualized management may include physical therapy, use of mechanical aids, surgical intervention for orthopedic complications, respiratory aids, and social and emotional support. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Stretching exercises to prevent contractures. </p>
          <p><italic toggle="yes">Surveillance:</italic> Annual monitoring of muscle strength, joint range of motion, and respiratory function; and for evidence of cardiomyopathy for subtypes with cardiac involvement.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Weight control to avoid obesity; avoidance of steroid treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Dysferlinopathy is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. Carrier testing for at-risk relatives and prenatal diagnosis for pregnancies at increased risk are possible if the pathogenic variants in the family are known. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="miyoshi.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="miyoshi.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_miyoshi.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">Dysferlinopathy: Included Disorders</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_miyoshi.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Miyoshi distal myopathy (Miyoshi myopathy)</p>
                    </list-item>
                    <list-item>
                      <p>Limb-girdle muscular dystrophy type 2B</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="miyoshi.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="miyoshi.Diagnosis">
        <title>Diagnosis</title>
        <p>Dysferlinopathy caused by <italic toggle="yes">DYSF</italic> pathogenic variants includes a spectrum of muscle disease characterized mainly by two phenotypes: Miyoshi myopathy with primarily distal weakness and limb-girdle muscular dystrophy type 2B (LGMD2B) with primarily proximal weakness.</p>
        <p><bold>Miyoshi myopathy</bold> is characterized by the following: </p>
        <list list-type="bullet">
          <list-item>
            <p>Mid- to late-childhood or early-adult onset; mean age at onset: 19.0 years [<xref ref-type="bibr" rid="miyoshi.REF.aoki.2001.271">Aoki et al 2001</xref>] </p>
          </list-item>
          <list-item>
            <p>Early and predominant involvement of the calf muscles </p>
          </list-item>
          <list-item>
            <p>Slow progression </p>
          </list-item>
          <list-item>
            <p>Elevation of serum CK concentration, often 10-100 times normal; mean CK: 8,940 IU/L [<xref ref-type="bibr" rid="miyoshi.REF.aoki.2001.271">Aoki et al 2001</xref>] </p>
          </list-item>
          <list-item>
            <p>Primarily myogenic pattern on EMG </p>
          </list-item>
          <list-item>
            <p>Biopsy evidence of a chronic, active myopathy without rimmed vacuoles </p>
          </list-item>
        </list>
        <p><bold>LGMD2B</bold> is characterized by the following: </p>
        <list list-type="bullet">
          <list-item>
            <p>Predominant weakness and atrophy of muscles of the pelvic and shoulder girdle </p>
          </list-item>
          <list-item>
            <p>Onset in the proximal lower-limb musculature in the late teens or later </p>
          </list-item>
          <list-item>
            <p>Massive elevation of serum CK concentration </p>
          </list-item>
          <list-item>
            <p>Slow progression </p>
          </list-item>
          <list-item>
            <p>Subclinical involvement of distal muscles, identified by careful examination or ancillary investigations such as muscle CT scan (in some individuals) </p>
          </list-item>
        </list>
        <sec id="miyoshi.Testing">
          <title>Testing</title>
          <p><bold>Muscle biopsy</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Histology.</bold> Muscle biopsy shows evidence of a dystrophy with random variation in fiber size and evidence of degeneration and regeneration. Type one fibers may predominate. There is often evidence of inflammation, sometimes leading to a misdiagnosis of polymyositis [<xref ref-type="bibr" rid="miyoshi.REF.gallardo.2001.2136">Gallardo et al 2001</xref>, <xref ref-type="bibr" rid="miyoshi.REF.fanin.2002.461">Fanin &#x00026; Angelini 2002</xref>, <xref ref-type="bibr" rid="miyoshi.REF.serratrice.2002.1025">Serratrice et al 2002</xref>, <xref ref-type="bibr" rid="miyoshi.REF.prelle.2003.537">Prelle et al 2003</xref>]. </p>
            </list-item>
            <list-item>
              <p><bold>Immunostaining.</bold> Antibodies to dysferlin identify a protein of approximately 230 kd and show that dysferlin is located in the muscle membrane [<xref ref-type="bibr" rid="miyoshi.REF.anderson.1999.855">Anderson et al 1999</xref>, <xref ref-type="bibr" rid="miyoshi.REF.matsuda.1999.1119">Matsuda et al 1999</xref>, <xref ref-type="bibr" rid="miyoshi.REF.eymard.2000.161">Eymard et al 2000</xref>]. Most individuals with <italic toggle="yes">DYSF</italic> pathogenic variants show complete deficiency of the protein or sometimes patchy sarcolemmal and cytoplasmic staining on muscle biopsy. Many individuals with partial deficiency of dysferlin have been reported [<xref ref-type="bibr" rid="miyoshi.REF.piccolo.2000.902">Piccolo et al 2000</xref>, <xref ref-type="bibr" rid="miyoshi.REF.matsuda.2001.1761">Matsuda et al 2001</xref>, <xref ref-type="bibr" rid="miyoshi.REF.saito.2002.615">Saito et al 2002</xref>]. </p>
            </list-item>
            <list-item>
              <p><bold>Immunoblot.</bold> Because of variable and nonspecific patterns, immunoblot is generally considered the more reliable method for testing. If possible, both immunostaining and immunoblotting should be performed [<xref ref-type="bibr" rid="miyoshi.REF.tagawa.2003.23">Tagawa et al 2003</xref>]. </p>
            </list-item>
          </list>
          <p><bold>Dysferlin expression.</bold> In individuals with dysferlinopathy, dysferlin immunoreactivity in peripheral blood monocytes cannot be detected using a commercially available monoclonal antibody [<xref ref-type="bibr" rid="miyoshi.REF.ho.2002.129">Ho et al 2002</xref>, <xref ref-type="bibr" rid="miyoshi.REF.ankala.2014.333">Ankala et al 2014</xref>]. </p>
          <sec id="miyoshi.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">DYSF</italic>, which encodes the protein dysferlin, is the only gene in which pathogenic variants are known to cause dysferlinopathy. </p>
            <table-wrap id="miyoshi.T.summary_of_molecular_genetic_t" position="anchor" orientation="portrait">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Dysferlinopathy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">DYSF</italic>
                    </td>
                    <td headers="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted mutation analysis&#x000a0;<sup>2,&#x000a0;3,&#x000a0;4</sup></td>
                    <td headers="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">95%</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_miyoshi.T.summary_of_molecular_genetic_t_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="miyoshi.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="miyoshi" object-id="miyohsi.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="miyoshi.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene. </p>
                </fn>
                <fn id="miyoshi.TF.1.2">
                  <label>2. </label>
                  <p>Note: Pathogenic variants included in a panel may vary by laboratory. </p>
                </fn>
                <fn id="miyoshi.TF.1.3">
                  <label>3. </label>
                  <p>Detects 1624delG pathogenic variant in Libyan Jews</p>
                </fn>
                <fn id="miyoshi.TF.1.4">
                  <label>4. </label>
                  <p>Detects 927delG pathogenic variant in Jews of the Caucasus [<xref ref-type="bibr" rid="miyoshi.REF.leshinskysilver.2007.950">Leshinsky-Silver et al 2007</xref>]</p>
                </fn>
                <fn id="miyoshi.TF.1.5">
                  <label>5. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="miyoshi.TF.1.6">
                  <label>6. </label>
                  <p>
                    <xref ref-type="bibr" rid="miyoshi.REF.takahashi.2003b.a233">Takahashi et al [2003b]</xref>
                  </p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="miyoshi.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Because there are number of conditions that lead to muscle weakness with an elevated CK level, a reasonable approach is to test a muscle biopsy for dysferlin using western immunoblotting. Absence of dysferlin protein almost always indicates a primary dysferlinopathy; however, it is important to note that reduced levels of dysferlin may be secondary to other primary muscular dystrophies [<xref ref-type="bibr" rid="miyoshi.REF.aoki.2001.271">Aoki et al 2001</xref>]. Further molecular genetic testing can then be pursued.</p>
          <p><bold>One genetic testing strategy</bold> is molecular genetic testing of <italic toggle="yes">DYSF</italic>, the only gene in which pathogenic variants are known to cause dysferlinopathy. </p>
          <list list-type="bullet">
            <list-item>
              <p>For individuals of Libyan Jewish ancestry or Jews of the Caucasus, targeted mutation analysis can be used for confirmation of the diagnosis and genetic counseling purposes. </p>
            </list-item>
            <list-item>
              <p>For individuals of other ethnic backgrounds, sequence analysis of the entire coding region can be pursued. </p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">DYSF</italic> and other genes of interest (see <xref ref-type="sec" rid="miyoshi.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time. </p>
        </sec>
      </sec>
      <sec id="miyoshi.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="miyoshi.Natural_History">
          <title>Clinical Description</title>
          <p>Several different clinical presentations have been observed [<xref ref-type="bibr" rid="miyoshi.REF.ueyama.2002.532">Ueyama et al 2002</xref>] and can occur within families having the same pathogenic variants [<xref ref-type="bibr" rid="miyoshi.REF.liu.1998.31">Liu et al 1998</xref>, <xref ref-type="bibr" rid="miyoshi.REF.weiler.1999.871">Weiler et al 1999</xref>, <xref ref-type="bibr" rid="miyoshi.REF.illarioshkin.2000.1931">Illarioshkin et al 2000</xref>, <xref ref-type="bibr" rid="miyoshi.REF.nakagawa.2001.15">Nakagawa et al 2001</xref>, <xref ref-type="bibr" rid="miyoshi.REF.ueyama.2001.139">Ueyama et al 2001</xref>]. The weakness and atrophy may be asymmetric with any of these presentations. </p>
          <p><bold>Miyoshi myopathy.</bold> Young adults have muscle weakness and atrophy most marked in the distal parts of the legs, especially the gastrocnemius and soleus muscles. Early on, affected individuals are not able to stand on tiptoe, but retain the ability to stand on the heels. Over a period of years, the weakness and atrophy spread to the thighs and gluteal muscles, at which time climbing stairs, standing, and walking become difficult. The forearms may become mildly atrophic with decrease in grip strength; the small muscles of the hands are spared. The weakness may eventually include the shoulder girdle muscles [<xref ref-type="bibr" rid="miyoshi.REF.mahjneh.2001.20">Mahjneh et al 2001</xref>]. </p>
          <p><bold>Limb-girdle muscular dystrophy syndrome.</bold> Early weakness and atrophy of the pelvic and shoulder girdle muscles begins in adolescence or young adulthood, with slow progression. </p>
          <p><bold>Scapuloperoneal syndrome.</bold> Occasionally, affected individuals present with initial weakness of the shoulder girdle muscles combined with distal weakness of the legs. </p>
          <p><bold>Distal myopathy with anterior tibial onset.</bold> Occasionally, leg weakness may involve the anterior compartment and cause foot drop [<xref ref-type="bibr" rid="miyoshi.REF.illa.2001.130">Illa et al 2001</xref>]. </p>
          <p><bold>Elevated serum CK concentration only.</bold> Some individuals have only a marked elevation of serum CK concentration. This is usually considered a presymptomatic presentation of myopathy in an individual who eventually develops muscle weakness and atrophy. Sometimes the calf muscles are enlarged; this presentation may be confused with a <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">dystrophinopathy</related-object> (i.e., Duchenne or Becker muscular dystrophy). </p>
          <p><bold>Congenital muscular dystrophy.</bold> Two sibs with hypotonia beginning between birth and age two months had delayed motor development and serum CK concentrations that were normal or slightly elevated before age three years [<xref ref-type="bibr" rid="miyoshi.REF.paradas.2009.21">Paradas et al 2009</xref>]. </p>
          <p>Of 41 Japanese individuals with proven dysferlinopathy, 20 had Miyoshi myopathy and 21 had LGMD2B (<xref ref-type="table" rid="miyoshi.T.comparison_of_miyoshi_myopathy">Table 2</xref>) [<xref ref-type="bibr" rid="miyoshi.REF.takahashi.2003b.a233">Takahashi et al 2003b</xref>]. On occasion, both phenotypes can be observed in affected sibs [<xref ref-type="bibr" rid="miyoshi.REF.liu.1998.31">Liu et al 1998</xref>]. </p>
          <table-wrap id="miyoshi.T.comparison_of_miyoshi_myopathy" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Comparison of Miyoshi Myopathy and LGMD2B</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"/>
                  <th id="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Miyoshi Myopathy</th>
                  <th id="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">LGMD2B</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Mean age at onset <break/>(range) </bold>
                  </td>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">21.8 &#x000b1; 7.4 yrs <break/>(14-37 yrs)</td>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">26.2 &#x000b1; 9.2 yrs<break/>(14-41 yrs)</td>
                </tr>
                <tr>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Average age of using a cane<break/>(yrs after onset) </bold>
                  </td>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">35.5 yrs <break/>(16 yrs)</td>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">39.3 yrs<break/>(13.6 yrs)</td>
                </tr>
                <tr>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Age at which wheelchair-bound<break/>(yrs after onset) </bold>
                  </td>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">42.8 yrs <break/>(22.8 yrs)</td>
                  <td headers="hd_h_miyoshi.T.comparison_of_miyoshi_myopathy_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">45.1 yrs<break/>(21.4 yrs)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>
                  <xref ref-type="bibr" rid="miyoshi.REF.takahashi.2003b.a233">Takahashi et al [2003b]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="miyoshi.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>One study reported that the 3370G&#x0003e;T pathogenic variant was associated with a milder form of Miyoshi myopathy and the 3510G&#x0003e;A pathogenic variant was associated with a more severe form [<xref ref-type="bibr" rid="miyoshi.REF.takahashi.2003a.1799">Takahashi et al 2003a</xref>, <xref ref-type="bibr" rid="miyoshi.REF.takahashi.2013.433">Takahashi et al 2013</xref>].</p>
        </sec>
        <sec id="miyoshi.Nomenclature">
          <title>Nomenclature</title>
          <p>Dysferlinopathy was originally called LGMD2B because at the time that it was mapped to 2p13 it was the second form (2) of autosomal recessive (B) limb-girdle muscular dystrophy (LGMD) to be mapped. The gene for Miyoshi myopathy and the gene for LGMD2B were mapped to the same genetic interval at chromosome 2p13. Two groups independently identified a novel human skeletal muscle gene, <italic toggle="yes">DYSF</italic>, at this locus and documented that <italic toggle="yes">DYSF</italic> pathogenic variants cause both Miyoshi myopathy and LGMD2B.</p>
        </sec>
        <sec id="miyoshi.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence is not known. In the initial (1967) description of Miyoshi myopathy, 50 out of 72 families were from Japan. <xref ref-type="bibr" rid="miyoshi.REF.tagawa.2003.23">Tagawa et al [2003]</xref> examined a total of 107 unrelated Japanese individuals, including 53 with unclassified LGMD, 28 with Miyoshi myopathy, and 26 with other neuromuscular disorders. Expression of dysferlin protein was observed using immunohistochemistry (IHC) and mini-multiplex Western blotting (MMW). They found a deficiency of dysferlin protein by using both IHC and MMW in 19% of individuals with LGMD and 75% of individuals with Miyoshi myopathy. </p>
          <p>In Libyan Jews, the prevalence is at least one per 1300, with a carrier rate of approximately 10% [<xref ref-type="bibr" rid="miyoshi.REF.argov.2000.1229">Argov et al 2000</xref>]. </p>
          <p>A founder mutation (Arg1905Ter) has been reported in Spain [<xref ref-type="bibr" rid="miyoshi.REF.vilchez.2005.1256">Vilchez et al 2005</xref>].</p>
        </sec>
      </sec>
      <sec id="miyoshi.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> have been associated with mutation of <italic toggle="yes">DYSF</italic>.</p>
      </sec>
      <sec id="miyoshi.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Dysferlinopathy needs to be distinguished from other autosomal recessive limb-girdle muscular dystrophies (see <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">Limb-Girdle Muscular Dystrophy Overview</related-object>).</p>
        <p>Individuals with LGMD generally show weakness and wasting restricted to the limb musculature, proximal greater than distal. Most individuals with LGMD show relative sparing of the heart and bulbar muscles, although exceptions occur, depending on the genetic subtype. Onset, progression, and distribution of the weakness and wasting vary considerably among individuals and genetic subtypes. </p>
        <p>The limb-girdle muscular dystrophies typically show degeneration/regeneration of muscle (dystrophic biopsy), which is usually associated with elevated serum creatine kinase concentration. Biochemical testing (i.e., protein testing by immunostaining) performed on a muscle biopsy can establish the diagnosis of the LGMD subtypes sarcoglycanopathy (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608099">608099</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604286">604286</ext-link>), <related-object link-type="booklink" source-id="gene" document-id="lgmd2a" document-type="chapter">calpainopathy</related-object>, and dysferlinopathy. In some cases, demonstration of complete or partial deficiencies for any particular protein can then be followed by molecular genetic studies of the corresponding gene.</p>
        <p>The <related-object link-type="booklink" source-id="gene" document-id="cav" document-type="chapter">caveolinopathies</related-object> are a group of muscle diseases caused by pathogenic variants in <italic toggle="yes">CAV3</italic>, which encodes caveolin-3, a muscle-specific membrane protein and the principal component of caveolae membrane in muscle cells in vivo. The caveolinopathies, which are inherited in an autosomal dominant manner, can be classified into five phenotypes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Limb-girdle muscular dystrophy 1C (LGMD1C) characterized by onset usually in the first decade, mild-to-moderate proximal muscle weakness, calf hypertrophy, positive Gower sign, and variable muscle cramps after exercise; </p>
          </list-item>
          <list-item>
            <p>Isolated hyperCKemia (i.e., elevated serum concentration of creatine kinase (CK) in the absence of signs of muscle disease) (HCK); </p>
          </list-item>
          <list-item>
            <p>Rippling muscle disease (RMD), characterized by signs of increased muscle irritability, such as percussion-induced rapid contraction (PIRC), percussion-induced muscle mounding (PIMM), and/or electrically silent muscle contractions (rippling muscle); </p>
          </list-item>
          <list-item>
            <p>Distal myopathy (DM), observed in one individual only;</p>
          </list-item>
          <list-item>
            <p>Hypertrophic cardiomyopathy (HCM), without skeletal muscle manifestations. </p>
          </list-item>
        </list>
        <p>The differential diagnosis also includes the <related-object link-type="booklink" source-id="gene" document-id="dbmd" document-type="chapter">dystrophinopathies</related-object> (Duchenne/Becker muscular dystrophy), polymyositis, and distal myopathies [<xref ref-type="bibr" rid="miyoshi.REF.udd.2001.561">Udd &#x00026; Griggs 2001</xref>].</p>
        <p>Other distal myopathies have been identified with clinical and genetic patterns as follows (see <xref ref-type="table" rid="miyoshi.T.distal_myopathies">Table 3</xref>). </p>
        <table-wrap id="miyoshi.T.distal_myopathies" position="anchor" orientation="portrait">
          <label>Table 3. </label>
          <caption>
            <p>Distal Myopathies</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Name</th>
                <th id="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mean Age at Onset</th>
                <th id="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Initial Muscle Group Involved</th>
                <th id="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Serum Creatine Kinase Concentration</th>
                <th id="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Muscle Biopsy</th>
                <th id="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene (Locus)&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1 hd_h_miyoshi.T.distal_myopathies_1_1_1_2 hd_h_miyoshi.T.distal_myopathies_1_1_1_3 hd_h_miyoshi.T.distal_myopathies_1_1_1_4 hd_h_miyoshi.T.distal_myopathies_1_1_1_5 hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" colspan="6" align="left" scope="col" rowspan="1">
                  <bold>Autosomal Dominant</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Welander distal myopathy (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604454">604454</ext-link>)</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;40 years</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Distal upper limbs (finger and wrist extensors)</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" rowspan="3" valign="middle" align="left" colspan="1">Normal or slightly increased</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rimmed vacuoles</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(2p13)</td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="udd" document-type="chapter">Udd distal myopathy</related-object>
                </td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;35</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">Anterior compartment in legs</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" colspan="1" align="left" rowspan="1">&#x000b1; Rimmed vacuoles</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">TTN </italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="mfm" document-type="chapter">Zaspopathy</related-object> (Markesbery-Griggs late-onset distal myopathy)</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;40</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" colspan="1" align="left" rowspan="1">Vacuolar and myofibrillar myopathy</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">LDB3 </italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="mfm" document-type="chapter">Distal myotilinopathy</related-object>
                </td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;40</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Posterior &#x0003e; anterior in legs</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Slightly increased</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Vacuolar and myofibrillar myopathy</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MYOT </italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><related-object link-type="booklink" source-id="gene" document-id="mpd1" document-type="chapter">Laing early-onset distal myopathy</related-object> (MPD1)</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;20</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Anterior compartment in legs and neck flexors</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Moderately increased</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Type 1 fiber atrophy in tibial anterior muscles; disproportion in proximal muscles</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MYH7 </italic>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Distal myopathy with vocal cord and pharyngeal signs (MPD2)</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">35-60</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Asymmetric lower leg and hands; dysphonia</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1-8 times</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rimmed vacuoles</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(5q)</td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Distal myopathy with pes cavus and areflexia</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15-50</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Anterior and posterior lower leg; dysphonia and dysphagia</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">2-6 times</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Dystrophic, rimmed vacuoles</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(19p13)</td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">New Finnish distal myopathy (MPD3)</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;30</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Hands or anterior lower leg</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1-4 times</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Dystrophic; rimmed vacuoles; eosinophilic inclusions</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">(8p22-q11 and 12q13-q22)</td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1 hd_h_miyoshi.T.distal_myopathies_1_1_1_2 hd_h_miyoshi.T.distal_myopathies_1_1_1_3 hd_h_miyoshi.T.distal_myopathies_1_1_1_4 hd_h_miyoshi.T.distal_myopathies_1_1_1_5 hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" colspan="6" align="left" scope="col" rowspan="1">
                  <bold>Autosomal Recessive</bold>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="ibm" document-type="chapter">Nonaka early-adult-onset distal myopathy</related-object>
                </td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15-20</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Anterior compartment in legs</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;10 times</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rimmed vacuoles</td>
                <td headers="hd_h_miyoshi.T.distal_myopathies_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GNE </italic>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>
                <xref ref-type="bibr" rid="miyoshi.REF.udd.2001.561">Udd &#x00026; Griggs [2001]</xref>
              </p>
            </fn>
            <fn id="miyoshi.TF.3.1">
              <label>1. </label>
              <p>Locus given only if the gene is not known</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="miyoshi.Management">
        <title>Management</title>
        <sec id="miyoshi.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis </title>
          <p>To establish the extent of disease and needs in an individual diagnosed with dysferlinopathy, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of strength and function in the arms, hands, legs, and feet; especially calf muscle </p>
            </list-item>
            <list-item>
              <p>If needed, measurement of serum CK concentration </p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="miyoshi.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>No definitive treatments exist for the limb-girdle muscular dystrophies. </p>
          <p>Management should be tailored to each individual and each specific subtype. A general approach to appropriate management can prolong survival and improve quality of life. This general approach is based on the typical progression and complications of individuals with LGMD as described by <xref ref-type="bibr" rid="miyoshi.REF.mcdonald.1995.s117">McDonald et al [1995]</xref> and <xref ref-type="bibr" rid="miyoshi.REF.bushby.1999.1403">Bushby [1999]</xref>.</p>
          <list list-type="bullet">
            <list-item>
              <p>Physical therapy and stretching exercises to promote mobility and prevent contractures </p>
            </list-item>
            <list-item>
              <p>Use of mechanical aids such as canes, walkers, orthotics, and wheelchairs as needed to help ambulation and mobility </p>
            </list-item>
            <list-item>
              <p>Surgical intervention as needed for orthopedic complications such as foot deformity and scoliosis </p>
            </list-item>
            <list-item>
              <p>Use of respiratory aids when indicated </p>
            </list-item>
            <list-item>
              <p>Social and emotional support and stimulation to maximize a sense of social involvement and productivity and to reduce the sense of social isolation common in these disorders </p>
            </list-item>
          </list>
        </sec>
        <sec id="miyoshi.Prevention_of_Secondary_Complica">
          <title>Prevention of Secondary Complications </title>
          <p>Stretching exercises to prevent contractures are indicated.</p>
        </sec>
        <sec id="miyoshi.Surveillance">
          <title>Surveillance</title>
          <p>The following surveillance is appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual monitoring of muscle strength, joint range of motion, and respiratory function </p>
            </list-item>
            <list-item>
              <p>Monitoring for evidence of cardiomyopathy in those subtypes with known occurrence of cardiac involvement </p>
            </list-item>
          </list>
        </sec>
        <sec id="miyoshi.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Control weight to avoid obesity; avoid use of steroids [<xref ref-type="bibr" rid="miyoshi.REF.walter.2013.26">Walter et al 2013</xref>].</p>
        </sec>
        <sec id="miyoshi.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk </title>
          <p>See <xref ref-type="sec" rid="miyoshi.Related_Genetic_Counseling_Issue">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="miyoshi.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>A double-blinded, placebo-controlled clinical trial of deflazacort in individuals with genetically confirmed dysferlinopathy has been completed [<xref ref-type="bibr" rid="miyoshi.REF.walter.2013.26">Walter et al 2013</xref>]. After six months of treatment, muscle strength did not improve; rather, there was a trend towards worsening muscle strength for affected individuals on deflazacort treatment. Muscle strength improved after the study drug was discontinued. Side effects included a broad spectrum typically seen in those taking steroids. Therefore, deflazacort treatment is not effective as a therapy for individuals with dysferlinopathies; additionally, the authors concluded that steroid treatment in general should be avoided in this condition [<xref ref-type="bibr" rid="miyoshi.REF.walter.2013.26">Walter et al 2013</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. </p>
        </sec>
      </sec>
      <sec id="miyoshi.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="miyoshi.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Dysferlinopathy is inherited in an autosomal recessive manner. </p>
        </sec>
        <sec id="miyoshi.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes and therefore carry one <italic toggle="yes">DYSF</italic> pathogenic variant. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. </p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier of a <italic toggle="yes">DYSF</italic> pathogenic variant is 2/3. </p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with dysferlinopathy are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">DYSF</italic>. </p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a <italic toggle="yes">DYSF</italic> pathogenic variant. </p>
        </sec>
        <sec id="miyoshi.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">DYSF</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="miyoshi.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals</p>
        </sec>
        <sec id="miyoshi.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">DYSF</italic> pathogenic variants have been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for families in which the pathogenic variants have been identified. </p>
        </sec>
      </sec>
      <sec id="miyoshi.Resources">
        <title>Resources</title>
      </sec>
      <sec id="miyoshi.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">DYS</italic> has 55 exons and 6,243 base-pair nucleotides in an open reading frame predicted to encode a protein of 2,080 amino acids. Recently, novel dysferlin transcripts were characterized by identifying alternative exons 1 of DYSF-v1 (GenBank DQ267935), exon 5a (GenBank DQ976379), and exon 40a (GenBank EF015906), although no pathogenic variant was identified in alternative exons [<xref ref-type="bibr" rid="miyoshi.REF.krahn.2009.439">Krahn et al 2009</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="miyoshi" object-id="miyoshi.molgen.TA">Table A</related-object>, <bold>Gene</bold>. </p>
        <p><bold>Pathogenic allelic variants.</bold>
<xref ref-type="bibr" rid="miyoshi.REF.argov.2000.1229">Argov et al [2000]</xref> identified the 1624delG pathogenic variant in 12 Libyan Jewish families with LGMD2B. Among Japanese individuals with Miyoshi myopathy, four pathogenic variants (1939C&#x0003e;G, 3370G&#x0003e;T, 3746delG, and 4870delT) account for 60% of all pathogenic variants [<xref ref-type="bibr" rid="miyoshi.REF.takahashi.2003a.1799">Takahashi et al 2003a</xref>]. The possible existence of a founder effect for the 2785C&#x0003e;T pathogenic variant in the Italian population was reported [<xref ref-type="bibr" rid="miyoshi.REF.cagliani.2003.788">Cagliani et al 2003</xref>]. Many pathogenic variants have been observed in individuals of various ethnic origins. These pathogenic variants were widely spread throughout the coding sequence of the gene without any mutational "hot spot" [<xref ref-type="bibr" rid="miyoshi.REF.cagliani.2005.283">Cagliani et al 2005</xref>, <xref ref-type="bibr" rid="miyoshi.REF.nguyen.2005.165">Nguyen et al 2005</xref>, <xref ref-type="bibr" rid="miyoshi.REF.krahn.2009.439">Krahn et al 2009</xref>]. </p>
        <p><bold>Normal gene product.</bold> Antibodies to dysferlin identify a protein of approximately 230 kd and show that dysferlin is located in the muscle membrane [<xref ref-type="bibr" rid="miyoshi.REF.anderson.1999.855">Anderson et al 1999</xref>, <xref ref-type="bibr" rid="miyoshi.REF.matsuda.1999.1119">Matsuda et al 1999</xref>]. Although the function of dysferlin is as yet unknown, dysferlin includes C2 domains thought to be important for calcium-mediated membrane fusion, and dysferlin was reported to have an essential role in the calcium-dependent membrane repair of skeletal muscle fibers [<xref ref-type="bibr" rid="miyoshi.REF.bansal.2003.168">Bansal et al 2003</xref>, <xref ref-type="bibr" rid="miyoshi.REF.bansal.2004.206">Bansal &#x00026; Campbell 2004</xref>]. </p>
        <p><xref ref-type="bibr" rid="miyoshi.REF.matsuda.2001.1761">Matsuda et al [2001]</xref> reported a possible interaction between dysferlin and caveolin-3 to subserve signaling functions of caveolae. <xref ref-type="bibr" rid="miyoshi.REF.lennon.2003.50466">Lennon et al [2003]</xref> reported an interaction between dysferlin and phospholipid- and calcium-binding annexins and suggested a role for annexins A1 and A2 in vesicle fusion during dysferlin-mediated membrane repair. <xref ref-type="bibr" rid="miyoshi.REF.matsuda.2005.334">Matsuda et al [2005]</xref> reported that affixin (beta-parvin), a novel, integrin-linked kinase-binding protein, is a dysferlin-binding protein that colocalizes with dysferlin at the sarcolemma of normal human skeletal muscle. The immunoreactivity of affixin was reduced in sarcolemma of Miyoshi myopathy and LGMD2B muscles, although the total amount of affixin protein was normal. </p>
        <p><bold>Abnormal gene product.</bold> While no correlations between mutation type and phenotype have been found, the 3510G&#x0003e;A pathogenic variant associated with the severe form of Miyoshi myopathy is located around a region of relative hydrophilia. <xref ref-type="bibr" rid="miyoshi.REF.takahashi.2003a.1799">Takahashi et al [2003a]</xref> speculate that this hydrophilic region may be important for the function of the protein. </p>
        <p>Disruption of the muscle membrane repair machinery is responsible for dysferlin-deficient muscle degeneration in dysferlin-null mice [<xref ref-type="bibr" rid="miyoshi.REF.bansal.2003.168">Bansal et al 2003</xref>, <xref ref-type="bibr" rid="miyoshi.REF.bansal.2004.206">Bansal &#x00026; Campbell 2004</xref>]. <xref ref-type="bibr" rid="miyoshi.REF.cenacchi.2005.190">Cenacchi et al [2005]</xref> reported that histopathologic, immunohistochemical, and ultrastructural analyses show muscle with dysferlinopathy to be characterized by a very active inflammatory/degenerative process, possibly associated with an inefficient repair and regenerative system. </p>
      </sec>
      <sec id="miyoshi.References">
        <title>References</title>
        <sec id="miyoshi.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="miyoshi.Literature_Cited.reflist0">
            <ref id="miyoshi.REF.anderson.1999.855">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davison</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cullen</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Britton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahjneh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fougerousse</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Dysferlin is a plasma membrane protein and is expressed early in human development.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>855</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">10196375</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.ankala.2014.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ankala</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nallamilli</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rufibach</surname>
                    <given-names>LE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hegde</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Diagnostic overview of blood-based&#x000a0;dysferlin&#x000a0;protein assay for dysferlinopathies.</article-title>
                <source>Muscle Nerve.</source>
                <volume>50</volume>
                <fpage>333</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24488599</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.aoki.2001.271">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Britton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keers</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oeltjen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>HE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchand</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bourg</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beley</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna-Yasek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majneh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barohn</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>271</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11468312</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.argov.2000.1229">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazor</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soffer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kahana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenmann</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features.</article-title>
                <source>Brain</source>
                <volume>123</volume>
                <fpage>1229</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">10825360</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.bansal.2004.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bansal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Dysferlin and the plasma membrane repair in muscular dystrophy.</article-title>
                <source>Trends Cell Biol</source>
                <volume>14</volume>
                <fpage>206</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">15066638</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.bansal.2003.168">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bansal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogel</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNeil</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Defective membrane repair in dysferlin-deficient muscular dystrophy.</article-title>
                <source>Nature</source>
                <volume>423</volume>
                <fpage>168</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">12736685</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.bushby.1999.1403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Making sense of the limb-girdle muscular dystrophies.</article-title>
                <source>Brain</source>
                <volume>122</volume>
                <fpage>1403</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">10430828</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.cagliani.2003.788">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cagliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortunato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaglia</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sironi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Angelo</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locatelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>13</volume>
                <fpage>788</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">14678801</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.cagliani.2005.283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cagliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortunato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamperti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodolico</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sironi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguennouz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciscato</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uncini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies.</article-title>
                <source>Hum Mutat</source>
                <volume>26</volume>
                <fpage>283</fpage>
                <pub-id pub-id-type="pmid">16100712</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.cenacchi.2005.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cenacchi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Giorgi</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism.</article-title>
                <source>J Clin Pathol</source>
                <volume>58</volume>
                <fpage>190</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15677541</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.eymard.2000.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tome</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leroy</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauw</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richard</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <comment>[Miyoshi distal myopathy: specific signs and incidence]</comment>
                <source>Rev Neurol (Paris)</source>
                <volume>156</volume>
                <fpage>161</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10743015</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.fanin.2002.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fanin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Muscle pathology in dysferlin deficiency.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <volume>28</volume>
                <fpage>461</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12445162</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.gallardo.2001.2136">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rojas-Garcia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Luna</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients.</article-title>
                <source>Neurology</source>
                <volume>57</volume>
                <fpage>2136</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11739845</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.ho.2002.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna-Yasek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luna</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A novel, blood-based diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy.</article-title>
                <source>Ann Neurol</source>
                <volume>51</volume>
                <fpage>129</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">11782994</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.illa.2001.130">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano-Munuera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rojas-Garcia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiget</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>130</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11198284</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.illarioshkin.2000.1931">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Illarioshkin</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanova-Smolenskaya</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nylen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sukhorukov</surname>
                    <given-names>VS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poleshchuk</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markova</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrogemann</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.</article-title>
                <source>Neurology</source>
                <volume>55</volume>
                <fpage>1931</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11134403</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.krahn.2009.439">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krahn</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borges</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Navarro</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuit</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torrente</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wein</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;cheux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000e9;vy</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Identification of different genomic deletions and one duplication in the dysferlin gene using multiplex ligation-dependent probe amplification and genomic quantitative PCR.</article-title>
                <source>Genet Test Mol Biomarkers.</source>
                <volume>13</volume>
                <fpage>439</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">19594366</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.lennon.2003.50466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lennon</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kho</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacskai</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perlmutter</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyman</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>50466</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">14506282</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.leshinskysilver.2007.950">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leshinsky-Silver</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozenboim</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzofi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirguin</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dabby</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lev</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>17</volume>
                <fpage>950</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17825554</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.liu.1998.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serrano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urtizberea</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamida</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Culper</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amato</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bossie</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oeltjen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bejaoui</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna-Yasek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosler</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schurr</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jong</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy.</article-title>
                <source>Nat Genet</source>
                <volume>20</volume>
                <fpage>31</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9731526</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.mahjneh.2001.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mahjneh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marconi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolvanen-Mahjneh</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>11</volume>
                <fpage>20</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11166162</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.matsuda.1999.1119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy.</article-title>
                <source>Neurology</source>
                <volume>53</volume>
                <fpage>1119</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10496277</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.matsuda.2001.1761">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>1761</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11532985</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.matsuda.2005.334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsuda</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kameyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>64</volume>
                <fpage>334</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15835269</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.mcdonald.1995.s117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abresch</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>WM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Kilmer</surname>
                    <given-names>DD</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Profiles of neuromuscular diseases. Limb-girdle syndromes.</article-title>
                <source>Am J Phys Med Rehab</source>
                <volume>74</volume>
                <fpage>S117</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">7576419</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.nakagawa.2001.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsuzaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suehara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanzato</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takashima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene.</article-title>
                <source>J Neurol Sci</source>
                <volume>184</volume>
                <fpage>15</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11231027</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.nguyen.2005.165">
              <mixed-citation publication-type="journal"><person-group><name name-style="western"><surname>Nguyen</surname><given-names>K</given-names></name><name name-style="western"><surname>Bassez</surname><given-names>G</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>R</given-names></name><name name-style="western"><surname>Krahn</surname><given-names>M</given-names></name><name name-style="western"><surname>Labelle</surname><given-names>V</given-names></name><name name-style="western"><surname>Figarella-Branger</surname><given-names>D</given-names></name><name name-style="western"><surname>Pouget</surname><given-names>J</given-names></name></person-group>Hammouda el H, Beroud C, Urtizberea A, Eymard B, Leturcq F, Levy N<year>2005</year><article-title>Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies.</article-title><source>Hum Mutat</source><volume>26</volume><fpage>165</fpage><pub-id pub-id-type="pmid">16010686</pub-id></mixed-citation>
            </ref>
            <ref id="miyoshi.REF.paradas.2009.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paradas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-Quereda</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luna</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Consuegra</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x000f3;mez</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallano</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A new phenotype of dysferlinopathy with congenital onset.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>19</volume>
                <fpage>21</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19084402</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.piccolo.2000.902">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Piccolo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campbell</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies.</article-title>
                <source>Ann Neurol</source>
                <volume>48</volume>
                <fpage>902</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">11117547</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.prelle.2003.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Prelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tancredi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fagiolari</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciscato</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serafini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortunato</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecca</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallanti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiveri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>105</volume>
                <fpage>537</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">12734659</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.saito.2002.615">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suehara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osame</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Miyoshi myopathy patients with novel 5' splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma.</article-title>
                <source>Acta Neuropathol (Berl)</source>
                <volume>104</volume>
                <fpage>615</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">12410383</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.serratrice.2002.1025">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Serratrice</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellissier</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N'Guyen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attarian</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pouget</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Dysferlinopathy. Example of a new myopathy.</article-title>
                <source>Bull Acad Natl Med</source>
                <volume>186</volume>
                <fpage>1025</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12587341</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.tagawa.2003.23">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamanaka</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishino</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>YK</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.</article-title>
                <source>J Neurol Sci</source>
                <volume>211</volume>
                <fpage>23</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12767493</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.takahashi.2013.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaginuma</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayasaka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugawara</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe-Kondo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimakura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuru</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakayama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobue</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funakawa</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukai</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawanami</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamazaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzuhara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshioka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konno</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>84</volume>
                <fpage>433</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">23243261</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.takahashi.2003a.1799">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuno</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takano</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamakura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mochizuki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shizuka-Ikeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akanuma</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoshino</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyachi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzuhara</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ibi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahashi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohnosu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonaka</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arahata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2003a</year>
                <article-title>Dysferlin mutations in Japanese Miyoshi myopathy: Relationship to phenotype.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1799</fpage>
                <lpage>804</lpage>
                <pub-id pub-id-type="pmid">12796534</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.takahashi.2003b.a233">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aoki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tateyama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshioka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konno</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>RH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2003b</year>
                <article-title>Mutational and clinical features of Japanese patients with dysferlinopathy.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <supplement>Suppl</supplement>
                <fpage>A233</fpage>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.udd.2001.561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Udd</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griggs</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Distal myopathies.</article-title>
                <source>Curr Opin Neurol</source>
                <volume>14</volume>
                <fpage>561</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11562566</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.ueyama.2002.532">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ueyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horinouchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aono</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical heterogeneity in dysferlinopathy.</article-title>
                <source>Intern Med</source>
                <volume>41</volume>
                <fpage>532</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12132520</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.ueyama.2001.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ueyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagao</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuda</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horinouchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>11</volume>
                <fpage>139</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">11257469</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.vilchez.2005.1256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lasa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rojas-Garcia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freixas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Luna</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calafell</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayordomo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiget</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illa</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Identification of a novel founder mutation in the DYSF gene causing clinical variability in the Spanish population.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>1256</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16087766</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.walter.2013.26">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schessl</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schreiber</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiners</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kress</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Reible</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrank</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deschauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlotter-Weigel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohnen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Treatment of dysferlinpathy with deflazacort: a double-blind, placebo-controlled clinical trial.</article-title>
                <source>Orphanet J Rare Dis</source>
                <volume>8</volume>
                <fpage>26</fpage>
                <pub-id pub-id-type="pmid">23406536</pub-id>
              </element-citation>
            </ref>
            <ref id="miyoshi.REF.weiler.1999.871">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weiler</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bashir</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>LV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davison</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Britton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nylen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vafiadaki</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wrogemann</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>871</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10196377</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="miyoshi.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="miyoshi.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>5 March 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>22 April 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 April 2006 (me) Comprehensive update posted to live Web site </p>
            </list-item>
            <list-item>
              <p>5 February 2004 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>24 September 2003 (ma) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
